Key result
Cardiac magnetic resonance imaging (CMR) enables risk stratification and prognostication for myocardial injury in COVID-19 by providing critical data on inflammation, fibrosis, and cardiac function.
CMR is a critical tool for the non-invasive evaluation, risk stratification, and prognostication of myocardial injury in patients with COVID-19.
Modified CMR protocols may enable safer myocarditis evaluation during outbreaks; leaves open need for validation of diagnostic yield and outcomes.
Myocardial injury is a common complication of the COVID-19 illness and is associated with a worsened prognosis. Systemic hyperinflammation seen in the advanced stage of COVID-19 likely contributes to myocardial injury. Cardiac magnetic resonance imaging (CMR) is the preferred imaging modality for non-invasive evaluation in acute myocarditis, enabling risk stratification and prognostication. Modified scanning protocols in the pandemic setting reduce risk of exposure while providing critical data regarding cardiac tissue inflammation and fibrosis, chamber remodeling, and contractile function. The growing use of CMR in clinical practice to assess myocardial injury will improve understanding of the acute and chronic sequelae of myocardial inflammation from various pathological etiologies.
No takes yet. Share an insight, caveat, or question.
Sanghvi et al. (2021) conducted a review in COVID-19 with myocardial injury. Cardiac magnetic resonance imaging (CMR) was evaluated. Cardiac magnetic resonance imaging (CMR) enables risk stratification and prognostication for myocardial injury in COVID-19 by providing critical data on inflammation, fibrosis, and cardiac function.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: